Berlin and Vaccines Poised for Progress

There are exciting reasons to be hopeful about the promise of vaccines—such as those using mRNA, which could be developed faster and cheaper.
 
Many of the quantum leaps in vaccine research, write Christopher J. Elias and Trevor Mundel, of the Bill & Melinda Gates Foundation, could happen in Germany.
 
With more math and science PhDs per capita than almost any other nation, Germany—host of this week’s World Health Summit in Berlin—is particularly well suited to lead in this field, and global health more generally, Elias and Mundel write. “More important, the German government has signaled that it wants to continue engaging with the fight against poverty and disease while other nations have started to retreat.”
 
Impatient Optimists (Commentary)

Comments +

0 comments

Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top